Adding a single cycle of rituximab to belimumab (Benlysta) did not improve disease control for patients with systemic lupus erythematosus (SLE) in comparison with belimumab alone in a phase 3 ...

Please provide your email address to receive an email when new articles are posted on . Rheumatologists opt for therapy regimens that include rituximab more often than nephrologists in treating ...

Recent randomized, controlled trials suggest that B-cell-depletion therapy with rituximab effectively induces remission in anti-neutrophil-cytoplasmic-antibody-associated vasculitis but is ineffective ...

In a new study, rituximab therapy was found to be an effective treatment option for lupus nephritis (LN) management. After six months of use, people with lupus nephritis taking the therapy showed ...

Full peer-reviewed results from the closely watched BEAT-LUPUS trial have now been published, confirming that systemic lupus erythematosus (SLE) patients can benefit from a one-two biologic punch. SLE ...

ATLANTA—Lupus nephritis patients who receive rituximab earlier in the course of their disease rather than later have better outcomes, new findings suggest. “We have been trying to use rituximab in a ...

Please provide your email address to receive an email when new articles are posted on . Belimumab after rituximab reduces serum IgG anti-double-stranded DNA antibody levels and the risk for severe ...

Prescription bottle Researchers evaluated the safety, mechanism of action, and preliminary efficacy of rituximab and cyclophosphamide followed by belimumab in the treatment of refractory lupus ...

In patients refractory to conventional therapy, the combination resulted in a 70% reduction in a key biomarker compared with placebo. A new study raises hopes that administration of belimumab ...

DUBLIN--(BUSINESS WIRE)--The "KOL Perspectives: Rituximab Use in Lupus" drug pipelines has been added to ResearchAndMarkets.com's offering. This KOL Insight briefing focuses on KOLs views of Rituximab ...

Treatment with the targeted drug rituximab can significantly benefit some patients with severe lupus nephritis who do not respond to conventional therapy, according to a study appearing in an upcoming ...

Long-term use of toxic immunosuppressive therapies for lupus nephritis could have particularly serious consequences in children. Nwobi et al. retrospectively assessed the safety and efficacy of the ...